Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: a nationwide population-based cohort study in Denmark
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Background Associations between HIV and schizophrenia in people with and without substance use disorders and the effect on timeliness of HIV diagnosis, antiretroviral therapy (ART), and treatment outcomes are poorly understood. We aimed to assess the association between HIV and schizophrenia and the effect on HIV treatment outcomes in people with and without substance use disorders.Methods We did a population-based cohort study with data from nationwide registries in Denmark to investigate the risk of schizophrenia after a diagnosis of HIV and the risk of HIV after a diagnosis of schizophrenia, accounting for substance misuse, timeliness of HIV diagnosis, and treatment success in relation to schizophrenia. We selected the cohort from people born in Denmark between Jan 1, 1955, and Dec 31, 1995, who we followed up from their 16th birthday or Jan 1, 1995 (whichever occurred last) until their death, emigration from Denmark, onset of schizophrenia, or Dec 31, 2011 (whichever came first). We estimated incidence rate ratios (IRRs) with Poisson and Cox regression, with adjustment for calendar period, and age and its interaction with sex.Findings We identified 2,786,286 individuals, of whom we included 2,646,154 people in analyses of risk of schizophrenia diagnosis and 2,658,662 people in analyses of risk of HIV diagnosis. In 35,353,633 person-years of follow up, HIV was associated with an increased risk of schizophrenia (IRR 4·09, 95% CI 2·73-5·83) and acute psychosis (7·15, 4·45-10·8); the IRR was highest within the first year of HIV diagnosis for both disorders (8·24, 2·95-17·7 and 12·7, 3·15-32·9, respectively). Schizophrenia was not associated with an increased risk of HIV in individuals without substance misuse disorders (IRR 1·42, 95% CI 0·81-2·27). The risk of schizophrenia in individuals with HIV decreased after ART (IRR 0·53, 0·32-0·87). The risk of acute psychosis did not differ between HIV-infected individuals receiving antiretroviral regimens with and without efavirenz (IRR 0·70, 95% CI 0·32-1·54). We recorded no differences in CD4 cell counts, time to ART, or viral suppression between individuals with schizophrenia with HIV and those without schizophrenia when substance use was taken into account. Between 1999 and 2011, the mortality rate ratio comparing HIV-infected individuals with schizophrenia with HIV-negative individuals without schizophrenia was 25·8 (95% CI 18·8-34·3).Interpretation Our findings emphasise the need for interventions to prevent HIV in people with schizophrenia, especially for those with substance use disorders, and for accessible mental health services for individuals with HIV.Funding Stanley Medical Research Institute, Lundbeck Foundation, Preben and Anna Simonsen Fund, Novo Nordisk Foundation, The Danish AIDS Foundation, and the Augustinus Foundation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients suffering from psychotic disorders were overrepresented here, similar to studies of homeless or precariously housed people worldwide. 3,41-43”
From The Hotel Study—Clinical and Health Service Effectiveness in a Cohort of Homeless or Marginally Housed Persons (2017) · cites this paper as [42]
Citations
Cites
The Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632
Self-citationThe Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
The Danish Civil Registration System. A cohort of eight million persons.
Pedersen, C. B., Gøtzsche, H., Møller, J. O., & Mortensen, P. B. (2006) · PubMed · Cited by 1,617
Self-citationThe Danish Psychiatric Central Research Register
Mors, O., Perto, G. P., & Mortensen, P. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810395825 · Cited by 1,589
Self-citationExcess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913
Self-citationHIV and risk environment for injecting drug users: the past, present, and future
Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60743-x · Cited by 559
Life expectancy and cardiovascular mortality in persons with schizophrenia
Laursen, T. M., Munk-Olsen, T., & Vestergaard, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835035ca · Cited by 518
Chander, G., Himelhoch, S., & Moore, R. D. (2006) · Drugs · doi:10.2165/00003495-200666060-00004 · Cited by 379
Uggerby, P., Østergaard, S. D., Røge, R., Correll, C. U., & Nielsen, J. (2013) · PubMed · Cited by 204
Cantor-Graae, E., & Pedersen, C. B. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.441 · Cited by 172
Self-citation
Cited by
COVID-19 and psychosis risk: real or delusional concern?
Watson, C. J., Thomas, R. H., Solomon, T., Michael, B. D., Nicholson, T. R., & Pollak, T. A. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135491 · Cited by 103
Discovering genetic interactions bridging pathways in genome-wide association studies
Fang, G., Wang, W., Paunić, V., Heydari, H., Costanzo, M., Liu, X., Liu, X., VanderSluis, B., Oately, B., Steinbach, M. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12131-7 · Cited by 116
Liang, C., Bai, Y., Hsu, J.-W., Huang, K., Ko, N., Chu, H., Yeh, T., Tsai, S., Chen, T., & Chen, M. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz126 · Cited by 76
Nanditha, N. G. A., Paiero, A., Tafessu, H. M., St‐Jean, M., McLinden, T., Justice, A. C., Kopec, J. A., Montaner, J. S. G., Hogg, R. S., & Lima, V. D. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041734 · Cited by 87
Onyeka, I. N., Høegh, M. C., Eien, E. M. N., Nwaru, B. I., & Melle, I. S. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1619007 · Cited by 83
Metadata
- Authors
- Helleberg, M., Pedersen, M. G., Pedersen, C. B., Mortensen, P. B., & Obel, N.
- Affiliations
- University of Copenhagen (DK)
- Aarhus University (DK)
- Corresponding author
- Helleberg, Marie
- Venue
- The Lancet HIV
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 2
- Issue
- 8
- Pages
- e344-e350
- ISSN
- 2352-3018 (ISSN-L)
- OpenAlex
- W1566836002
- Cited by
- 56
- References
- 29
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 9 · 2019: 6 · 2018: 5 · 2017: 8 · 2016: 1 · 2015: 3
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet HIV (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Stanley Medical Research Institute
- Lundbeckfonden (R155-2014-1724)
- Anna Fonds|NOREF
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV, schizophrenia, substance use disorders, antiretroviral therapy, efavirenz, acute psychosis, HIV treatment outcomes, psychiatric comorbidity
- MeSH terms
- Adult, Denmark, Female, Follow-Up Studies, Humans, Male, Psychotic Disorders, Registries, Risk Factors, Schizophrenia, Cohort Studies, HIV Infections, Incidence, Treatment Outcome, CD4 Lymphocyte Count, Substance-Related Disorders, Antiretroviral Therapy, Highly Active
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: a nationwide population-based cohort study in Denmark. https://app.cochat.ai/papers/10.1016/s2352-3018(15)00089-2
- The paper
- Helleberg, M., Pedersen, M. G., Pedersen, C. B., Mortensen, P. B., & Obel, N. (2015). Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: a nationwide population-based cohort study in Denmark. The Lancet HIV. https://doi.org/10.1016/s2352-3018(15)00089-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.